The Precision Peptide Company Inc. (CSE:BPC)
Canada flag Canada · Delayed Price · Currency is CAD
0.470
-0.010 (-2.08%)
At close: Apr 27, 2026

CSE:BPC Income Statement

Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jan '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Revenue
0.090.050.010.290.580.12
Revenue Growth (YoY)
2116.42%307.47%-95.73%-50.84%394.79%-
Cost of Revenue
0.040.030.070.320.540.13
Gross Profit
0.060.02-0.06-0.030.04-0.01
Selling, General & Admin
2.622.160.791.230.820.28
Research & Development
0.060.030.03---
Operating Expenses
3.552.270.961.610.940.28
Operating Income
-3.49-2.25-1.02-1.64-0.9-0.3
Interest & Investment Income
0.010.01----
Currency Exchange Gain (Loss)
0-0.030-0.01-0.01-0
Other Non Operating Income (Expenses)
-----0.19-
EBT Excluding Unusual Items
-3.48-2.28-1.02-1.65-1.09-0.3
Impairment of Goodwill
-0.88-0.88----
Asset Writedown
-1.37-1.37-0.01-0.01-0.04-
Pretax Income
-5.73-4.53-1.03-1.66-1.13-0.3
Net Income
-5.73-4.53-1.03-1.66-1.13-0.3
Net Income to Common
-5.73-4.53-1.03-1.66-1.13-0.3
Shares Outstanding (Basic)
30227651
Shares Outstanding (Diluted)
30227651
Shares Change (YoY)
326.12%224.08%17.56%24.54%589.41%-
EPS (Basic)
-0.19-0.21-0.15-0.29-0.25-0.45
EPS (Diluted)
-0.19-0.21-0.15-0.29-0.25-0.45
Free Cash Flow
-2.73-2.33-0.44-0.98-0.72-0.95
Free Cash Flow Per Share
-0.09-0.11-0.07-0.17-0.16-1.43
Gross Margin
61.96%44.15%--11.48%7.04%-10.69%
Operating Margin
-3764.63%-4529.94%-8354.01%-575.40%-154.78%-252.00%
Profit Margin
-6179.87%-9104.28%-8450.19%-581.35%-194.13%-252.86%
Free Cash Flow Margin
-2944.71%-4694.10%-3601.16%-343.39%-123.69%-808.45%
EBITDA
-3.38-2.16-1.02-1.64-0.9-0.29
EBITDA Margin
-----154.64%-250.67%
D&A For EBITDA
0.110.090000
EBIT
-3.49-2.25-1.02-1.64-0.9-0.3
EBIT Margin
-----154.78%-252.00%
Advertising Expenses
-0.590.040.380.27-
Source: S&P Capital IQ. Standard template. Financial Sources.